Abstract
Wilms' tumour probably arises from embryonal kidney cells and occurs in both hereditary and sporadic forms1. Knudson and Strong have suggested that both forms of the disease are initiated by two mutational events2. In the case of the inherited form, cytogenetic evidence indicates that a germline deletion of chromosome band 11p13 may correspond to one of the two mutations3–5. DNA mapping evidence is consistent with the notion that the tumour susceptibility gene (Wg) on chromosome 11 is actually recessive6–9. Comings has proposed that the dominantly inherited tumours may arise by the inactivation or loss of a diploid pair of regulatory genes which normally suppress the expression of a structural transforming gene (Tg)10. It has recently been suggested that the N-myc oncogene may serve as a transforming gene in retinoblas-toma11, although no such gene has yet been identified in Wilms' tumour. We now report that in four cases of Wilms' tumour, insulin-like growth factor-II (IGF-II) transcripts are highly elevated compared with the adjacent normal kidney. In addition, we have mapped the gene for IGF-II to chromosome band 11p14.1, which is in the immediate vicinity of Wg. These findings suggest that IGF-II may be involved in the aetiology of Wilms' tumour.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gonzalez-Crussi, F. (ed.) & Franklin, W. A. in Wilms' Tumour and Related Renal Neoplasms of Childhood, 7 (CRC Press, Boca Raton, 1984).
Knudson, A. G. Jr & Strong, L. C. J. natn. Cancer Inst. 48, 313–342 (1972).
Riccardi, V. M., Sujansky, E., Smith, A. C. & Francke, U. Pediatrics 61, 604–610 (1978).
Francke, U., Holmes, L. B., Atkins, L. & Riccardi, V. M. Cytogenet. Cell Genet. 24, 185–192 (1979).
Yunis, J. J. & Ramsay, N. K. C. J. Pediat. 96, 1027–1030 (1980).
Koufos, A. et al. Nature 309, 170–172 (1984).
Orkin, S. H., Goldman, D. S. & Sallan, S. E. Nature 309, 172–174 (1984).
Reeve, A. E. et al. Nature 309, 174–176 (1984).
Fearon, E. R., Vogelstein, B. & Feinberg, A. P. Nature 309, 176–178 (1984).
Comings, D. E. Proc. natn. Acad. Sci. U.S.A. 70, 3324–3328 (1973).
Lee, W. H., Murphree, A. L. & Benedict, W. F. Nature 309, 458–460 (1984).
Strobel, R. J., Riccardi, V. M., Ledbetter, D. H. & Hittner, H. M. Am. J. med. Genet. 7, 15–20 (1980).
de Martinville, B. & Francke, U. Nature 305, 641–643 (1983).
Hittner, H. M., Riccardi, V. M. & Francke, U. Ophthalmology 86, 1173–1183 (1979).
Bell, G. I. et al. Nature 310, 775–777 (1984).
Brissenden, J. E., Ullrich, A. & Francke, U. Nature 310, 781–784 (1984).
Tricoli, J. V., Rail, L. B., Scott, J., Bell, G. I. & Shows, T. B. Nature 310, 784–786 (1984).
Slater, R. M. & de Kraker, J. Cancer Genet. Cytogenet. 5, 237–245 (1982).
Narahara, K. et al. Hum. Genet. 66, 181–185 (1984).
Gardner, R. J. M., Grindley, R. M., Chewings, W. E. & Holdaway, M. D. H. Proc. Univ. Otago med. Sch. 61, 32–34 (1983).
Thiele, C. J., Reynolds, C. P. & Israel, M. A. Nature 313, 404–406 (1985).
Maniatis, T., Fritsch, E. F. & Sambrook, J. in Molecular Cloning, 202 (Cold Spring Harbor Laboratory, New York, 1982).
Huerre, C., Despoisse, S., Gilgenkrantz, S., Lenoir, G. M. & Junien, C. Nature 305, 638–641 (1983).
Jhanwar, S. C., Neel, B. G., Hayward, W. S. & Chaganti, R. S. K. Proc. natn. Acad. Sci. U.S.A. 80, 4794–4797 (1983).
Harper, M. E., Ullrich, A. & Saunders, G. F. Proc. natn. Acad. Sci. U.S.A. 78, 4458–4460 (1981).
Raizis, A. M., Becroft, D. M., Shaw, R. L. & Reeve, A. E. Hum. Genet. (in the press).
Dulak, N. C. & Temin, H. M. J. cell. Physiol. 81, 153–160 (1973).
Nissley, S. P., Rechler, M. M., Moses, A. C., Short, P. A. & Podskalny, J. M. Endocrinology 101, 708–716 (1977).
Moses, A. C., Cohen, K. L., Johnsonbaugh, R. & Nissley, S. P. Clin. Endocr. Metab. 46, 937–946 (1978).
Moses, A. C. et al. Proc. natn. Acad. Sci. U.S.A. 77, 3649–3653 (1980).
Adams, S. O., Nissley, S. P., Handwerger, S. & Rechler, M. M. Nature 302, 150–153 (1983).
Rabin, M. et al. Cytogenet. Cell Genet. 38, 70–72 (1984).
Bernheim, A., Berger, R. & Szabo, P. Chromosoma 89, 163–167 (1984).
Chirgin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Rigby, P. W. J., Dieckmann, M., Rhodes, C. & Berg, P. J. biol. Chem. 113, 234–251 (1977).
Shih, C. & Weinberg, R. A. Cell 29, 161–169 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reeve, A., Eccles, M., Wilkins, R. et al. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317, 258–260 (1985). https://doi.org/10.1038/317258a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/317258a0
This article is cited by
-
Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer
Journal of Ovarian Research (2023)
-
Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor
Oncogene (2021)
-
The role of insulin-like growth factor I–II receptor on development of pleomorphic adenoma
European Archives of Oto-Rhino-Laryngology (2017)
-
Hepatic Hemangiopericytoma/Solitary Fibrous Tumor: A Review of Our Current Understanding and Case Study
Journal of Gastrointestinal Surgery (2012)
-
The IGF system
Acta Diabetologica (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.